Predictors of survival in dementia with Lewy bodies and Parkinson dementia

Neurodegenerative Diseases

Volumn 4, Issue 6, 2007, Pages 428-430

  Jellinger, Kurt A ^a   Wenning, Gregor K ^b   Seppi, Klaus ^b  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alzheimer pathology; Dementia with Lewy bodies; Fluctuating cognition; Parkinson disease with dementia; Predictors; Survival

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 35048814562     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000107703     Document Type: Article

References (12)

1. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
2. Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, et al: Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003;60:1586-1590.
3. Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, et al: Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006;67:1931-1934.
4. Williams MM, Xiong C, Morris JC, Galvin JE: Survival and mortality differences between dementia with Lewy bodies vs. Alzheimer disease. Neurology 2006;67:1935-1941.
5. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP: What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;68:434-440.
6. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, et al: DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007;68:812-819.
7. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
8. Jellinger KA: Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. J Neural Transm 2003;110:771-778.
9. Jellinger KA, Seppi K, Wenning GK, Poewe W: Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 2002;109:329-339.
10. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, et al: Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-620.
11. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD: An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology 1990;40:763-766.
12. Kramer ML, Schulz-Schaeffer WJ: Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007;27:1405-1410.